메디컬투데이 - 종근당 ‘이모튼캡슐’ 효능ㆍ효과 축소에 급여기준도 조정

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

https://www.alphabiz.co.kr/news/view/1065550038334688

This article is based on global economic content from Alphabiz, which distributes English-language news on Korean markets and companies to international audiences.

[ⓒ 메디컬투데이. 무단전재-재배포 금지]